Author

Nwamaka Obidegwu

Observed name: N Obidegwu

Institutions: University of North Carolina at Chapel Hill, Mayo Clinic, University of California San Diego, Dana-Farber Cancer Institute, Dr. Susan Love Foundation for Breast Cancer Research

Observed institutions: University of North Carolina at Chapel Hill, Mayo Clinic, Health Net, University of California San Diego, Dana-Farber Cancer Institute, Dr. Susan Love Foundation for Breast Cancer Research

OpenAlex ID: A5010325525

Regimen-Specific Rates of Chemotherapy-Related Amenorrhea in Breast Cancer Survivors

2019 · Kelly C Gast, Elizabeth J Cathcart-Rake, et al. · JNCI Cancer Spectrum · 12

Accuracy of self-reported cancer treatment data in young breast cancer survivors

2019 · Kelly C. Gast, Elizabeth J. Cathcart-Rake, et al. · Journal of Patient-Reported Outcomes · 8

Metastatic Breast Cancer Collateral Damage (MBCCD) project: Think tank of advocates and provider-survivors.

2017 · Leah Eshraghi, Heather Cooper Ortner, et al. · Journal of Clinical Oncology · 3

Abstract P1-12-10: Regimen-specific rates of chemotherapy-related amenorrhea in breast cancer survivors

2019 · KC Gast, EJ Cathcart-Rake, et al. · Cancer Research

Accuracy of self-reported chemotherapy regimens in young breast cancer survivors.

2018 · Kelly C. Gast, Elizabeth Jane Cathcart-Rake, et al. · Journal of Clinical Oncology

Metastatic Breast Cancer Collateral Damage (MBCCD) project: Addressing unique needs and identifying patients at highest risk.

2017 · Jessica Noelle Clague DeHart, Annette Stanton, et al. · Journal of Clinical Oncology

Works count: 6

Citation count: 23

H-index: 3

I10-index: 1